Quick Answer
NovoCure Ltd reported Gross Profit of $488.47 million for fiscal year 2025.
NovoCure Ltd Gross Profit — Annual History
| Fiscal Year | Gross Profit | YoY Change |
|---|---|---|
| 2025 | $488.47M | +4.4% |
| 2024 | $468.04M | +22.8% |
| 2023 | $381.06M | -9.9% |
| 2022 | $422.97M | +0.7% |
| 2021 | $420.15M | +8.3% |
| 2020 | $387.87M | +47.6% |
| 2019 | $262.71M | +56.4% |
| 2018 | $168.02M | +38.4% |
| 2017 | $121.42M | +231.7% |
| 2016 | $36.61M | +193.4% |
| 2015 | $12.48M | +128.8% |
| 2014 | $5.45M | +63.0% |
| 2013 | $3.35M | — |
Quarterly Gross Profit
| Quarter Ending | Gross Profit | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $122.47M | +2.3% | +4.4% |
| June 30, 2025 | $117.33M | +1.4% | +0.7% |
| March 31, 2025 | $116.47M | +11.1% | -2.7% |
| September 30, 2024 | $119.72M | +25.7% | +3.5% |
| June 30, 2024 | $115.70M | +25.7% | +10.4% |
| March 31, 2024 | $104.81M | +13.2% | +10.1% |
| September 30, 2023 | $95.23M | -5.9% | +3.5% |
| June 30, 2023 | $92.03M | -18.1% | -0.6% |
- NovoCure Ltd showed an increase of +4.4% in Gross Profit compared to the prior fiscal year.
- Over the 2013–2025 period, NovoCure Ltd’s gross profit has grown by 14498.7% (from $3.35 million to $488.47 million).
- The most recent figure is from NovoCure Ltd’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: